Catalyst Wire Dossier Catalyst Wire Dossier

Pitavastatin/Ezetimibe fixed-dose combination

Pitavastatin; Ezetimibe · Boryung Pharmaceutical Co., Ltd
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Pitavastatin/Ezetimibe fixed-dose combination, covering 2025-09-12 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Pitavastatin/Ezetimibe in Dyslipidemia Patients With Metabolic Syndrome: An Observational Study

See pricing